|
1
|
Barton ME, Steen BVD, Van Tricht HL, Byrnes W, Purcell FE, Southcott SA, Raby D, Starshinov YI, Ewen C. Update on the TOGETHER study: a patient‐ and investigator‐blind, randomized, placebo‐controlled study evaluating the efficacy, safety and tolerability of bepranemab, UCB0107, in prodromal‐to‐mild Alzheimer’s disease. Alzheimers Dement 2022. [DOI: 10.1002/alz.068973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|